Multiple Sclerosis Drugs Market | Competitive Landscape [2032]
WEBSep 2, 2024 · The reallocation of healthcare resources for COVID-19 treatment, fewer people going for the disease diagnosis, and supply chain disruptions impacted the sales of these drugs for the treatment of MS. The market experienced slow growth in 2021 as well.
A view into the central nervous system disorders market - Nature
WEBSep 1, 2020 · Therapies for multiple sclerosis (MS) accounted for 7 of the top 15 CNS products and 26% of CNS product sales in 2019—the highest market share, largely driven by products such as Biogen’s...
Multiple Sclerosis (MS) Market Outlook and Forecast - Thelansis
WEBMay 13, 2023 · Multiple Sclerosis (MS) Market Forecast: Patient Based Forecast Model (MS. Excel Based Automated Dashboard) Data Inputs with sourcing, Market Event, Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, …
Multiple Sclerosis (MS) Drugs Market Size to Hit Sales of
WEBWASHINGTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Global multiple sclerosis drugs market size was $25.1 Billion in 2021 and is estimated to generate revenue of $31.2 Billion by 2028 at a CAGR of...
Multiple Sclerosis Therapeutic Market Size Report, 2030
WEBThe global multiple sclerosis therapeutic market size was valued at USD 25.94 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030.The market growth is due to the rise in the global prevalence of the disease, and the advancements in the treatment which have led to the development of disease-modifying therapies (DMTs) that...
Multiple sclerosis market to generate sales of $29.8 ... - GlobalData
WEBApr 18, 2023 · The market for multiple sclerosis (MS) disease-modifying therapies is set to experience moderate growth across the seven major markets, says GlobalData.
Ocrevus on top: How Roche is dominating MS sales - BioCentury
WEBMay 23, 2022 · Ocrevus ocrelizumab, an intravenously administered humanized anti-CD20 mAb from Roche (SIX:ROG; OTCQX:RHHBY), has led the market in global MS sales since 3Q20. It is Roche’s top-selling therapy, bringing in over $1.5 billion in sales in 1Q22.
Multiple sclerosis market to generate sales of $29.8 billion by 2030
WEBApr 18, 2023 · Multiple sclerosis market to generate sales of $29.8 billion by 2030. MS is a primary autoimmune disease leading to the degeneration of the central nervous system. GlobalData Healthcare April 18, 2023. The main driver for MS market growth will be the anticipated launch of 10 new pipeline products. Credit: Kateryna Kon via Shutterstock.
The multiple sclerosis market - Nature Reviews Drug Discovery
WEBJun 23, 2017 · Current market. Worldwide, MS affects ~2.3 million people: the majority of patients (~85%) have RFMS, 5% have PRMS and 10% have PPMS. Despite this small global prevalence, MS has been one of...
Global Multiple Sclerosis Market - Data Bridge Market Research
WEBData Bridge Market Research analyses that the multiple sclerosis market was valued at USD 25.32 billion in 2021 and is expected to reach USD 33.98 billion by 2029, registering a CAGR of 3.75% during the forecast period of 2022 to 2029.
- Reviews: 51
- Some results have been removed